Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
Jirí Masopust,1,2 Ctirad Andrýs,3 Jan Bažant,1 Oldrich Vyšata,4 Kamil Kuca,5 Martin Vališ4 1Department of Psychiatry, Faculty of Medicine in Hradec Kralové, Charles University in Prague, University Hospital Hradec Králové...
Enregistré dans:
Auteurs principaux: | Masopust J, Andrýs C, Bažant J, Vyšata O, Kuca K, Vališ M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a96b3b64f3a242ba89940aa0d4ee656a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
par: Urban-Kowalczyk M, et autres
Publié: (2019) -
Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia
par: Washida K, et autres
Publié: (2013) -
Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
par: Matei VP, et autres
Publié: (2020) -
Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
par: Adam UU, et autres
Publié: (2014) -
Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
par: Pu C, et autres
Publié: (2020)